Skip to main content
Log in

Genotyping and drug response: Use of single nucleotide polymorphisms (SNPs) versus haplotypes to predict albuterol efficacy

  • Published:
AAPS PharmSci Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Drysdale, C. M. et al. (2000) Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. PNAS 97, 10483–10488

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Martinez, F. D. et al. (1997) Association between genetic polymorphisms of the β2-adrenoceptor and response to albuterol in children with and without a history of wheezing. Journal of Clinical Investigation 100, 3184–3188

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Green, S. A. et al. (1994). Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33, 9414–9419

    Article  CAS  PubMed  Google Scholar 

  4. Reihsaus, E. et al. (1993). Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 8, 334–349.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suzanne Schubbert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schubbert, S. Genotyping and drug response: Use of single nucleotide polymorphisms (SNPs) versus haplotypes to predict albuterol efficacy. AAPS PharmSci 3, Commentary 1 (2001). https://doi.org/10.1208/ps0303_commentary1

Download citation

  • Published:

  • DOI: https://doi.org/10.1208/ps0303_commentary1

Keywords

Navigation